AU2003260793A1 - Therapeutic compositions comprising a boron-containing compound - Google Patents

Therapeutic compositions comprising a boron-containing compound

Info

Publication number
AU2003260793A1
AU2003260793A1 AU2003260793A AU2003260793A AU2003260793A1 AU 2003260793 A1 AU2003260793 A1 AU 2003260793A1 AU 2003260793 A AU2003260793 A AU 2003260793A AU 2003260793 A AU2003260793 A AU 2003260793A AU 2003260793 A1 AU2003260793 A1 AU 2003260793A1
Authority
AU
Australia
Prior art keywords
boron
containing compound
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260793A
Other versions
AU2003260793A8 (en
Inventor
Ian Flockhart
Bipin Patel
Ken Rickwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psimei Pharmaceuticals PLC
Original Assignee
Psimei Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals PLC filed Critical Psimei Pharmaceuticals PLC
Publication of AU2003260793A8 publication Critical patent/AU2003260793A8/en
Publication of AU2003260793A1 publication Critical patent/AU2003260793A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003260793A 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound Abandoned AU2003260793A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0222945.8 2002-10-03
GBGB0222945.8A GB0222945D0 (en) 2002-10-03 2002-10-03 Therapeutic compositions
PCT/GB2003/003870 WO2004030661A2 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound

Publications (2)

Publication Number Publication Date
AU2003260793A8 AU2003260793A8 (en) 2004-04-23
AU2003260793A1 true AU2003260793A1 (en) 2004-04-23

Family

ID=9945241

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260793A Abandoned AU2003260793A1 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound

Country Status (3)

Country Link
AU (1) AU2003260793A1 (en)
GB (1) GB0222945D0 (en)
WO (1) WO2004030661A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863484B1 (en) * 2003-12-11 2007-04-13 Oreal USE OF COMPOUNDS CAPABLE OF ACTING ON THE METABOLIC PATHWAY CONTROLLED BY DOPACHROME TAUTOMERASE TRP-2 AS PROTECTIVE AGENT OF MELANOCYTES OF FOLLICLE AND APPLICATIONS
GB0404708D0 (en) * 2004-03-02 2004-04-07 Cellic As T Boron containing nanoparticles
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
KR102586137B1 (en) 2017-04-07 2023-10-05 노쓰 캐롤라이나 스테이트 유니버시티 Additives for fiber reinforcement
BR112021006338A2 (en) 2018-10-05 2021-07-06 Univ North Carolina State cellulosic fiber processing
CN111117124B (en) * 2018-10-30 2021-02-12 华南理工大学 Hot water soluble polyvinyl alcohol film and preparation method and application thereof
KR102562968B1 (en) * 2018-11-01 2023-08-04 주식회사 셀비온 p-Boronophenylalanine composition for Boron Neutron Capture Therapy and preparing method thereof
JP7297077B2 (en) * 2019-04-26 2023-06-23 南京中硼▲聯▼康医▲療▼科技有限公司 BPA freeze-dried formulation and manufacturing method
CA3151049A1 (en) * 2019-09-12 2021-03-18 Stella Pharma Corporation Method for preventing precipitation of injectable solution containing p-boronophenylalanine
CN118662456A (en) * 2023-03-15 2024-09-20 中硼(厦门)生物医药有限公司 Preparation method of large-size dihydroxyboryl phenylalanine freeze-dried powder injection and freeze-dried powder injection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
US6169076B1 (en) * 1999-03-31 2001-01-02 Glcosyn Pharmaceuticals, Inc. P-Boronophenylalanine complexes with fructose and related carbohydrates and polyols

Also Published As

Publication number Publication date
WO2004030661A3 (en) 2004-09-30
GB0222945D0 (en) 2002-11-13
WO2004030661A2 (en) 2004-04-15
AU2003260793A8 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003235759A1 (en) 4-dedimethylamino tetracycline compounds
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003279366A1 (en) Novel compounds
AU2003276549A1 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
AU2003236353A1 (en) Photopolymerizable composition
AU2003216053A1 (en) Guanidino compounds
AU2003260793A1 (en) Therapeutic compositions comprising a boron-containing compound
AUPR409401A0 (en) Analgesic compound
AUPS222802A0 (en) Adjuvant composition
AU2003282722A1 (en) Therapeutic compositions
AU2003215150A1 (en) Therapeutic compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003208621A1 (en) A pharmaceutical composition
AUPS044102A0 (en) New compound
AU2003280799A1 (en) Medicinal composition
AU2002951868A0 (en) Compound i
AU2003222571A1 (en) Novel therapeutic application for a composition
AU2003208841A1 (en) Gasolinen compositions
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds
AU2003275480A1 (en) Compounds
AU2003255322A1 (en) Compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase